The term dementia denotes a group of symptoms the most important of which is memory loss. With this symptom there are other symptoms that lead to more pronounced damage to cognitive function but also to the increasing dependence of the assisted person on the assistance of the fellow. Also, there are speech disorders, no complicated actions, and the inability to identify with the preserved vision. Regardless of the fact that most dementia is considered irreversible and progressive, it is important to timely set up a diagnosis of illness and start causative and symptomatic treatment on time. AIM OF THE WORK:Determine the use of psychopharmaceuticals in dementia patients treated at KBC Rijeka Clinical Psychiatry for a period of five years. METHODS OF WORK:The data were collected from the medical documentation of the Institute for Clinical Psychiatry on the use of psychopharmaceuticals in a time period from 2013 to 2018 year that has all been approved by the Ethical Commission of KBC Rijeka. THE RESULTS:From the study conducted, it is apparent that the presence of vascular dementia is about half of all dementia in Kbc Rijeka. Furthermore, younger people are more likely to have prescribed benzodiazepine therapy, while Alzheimer's disease is more commonly prescribed antidemic. The most commonly prescribed therapy is the anxiolytics, while the antipsychotics are in another place. CONCLUSION: From the results obtained we can conclude that a timely start of treatment with antidemics in early stages of dementia would be more effective, ie slowing down the course of the disease, which would contribute to better quality of life of the patients themselves and then their families and reduce or at least postpone hospitalization as and the consumption of other psycho-drugs, especially anxiolytics, and antipsychotics, which is a major economic problem for health institutions and the whole.